Lyons AB - Search Results

1

Inhibition of c-fms by imatinib: expanding the spectrum of treatment.

Dewar AL, Zannettino AC, Hughes TP, Lyons AB. Dewar AL, et al. Among authors: lyons ab. Cell Cycle. 2005 Jul;4(7):851-3. doi: 10.4161/cc.4.7.1788. Epub 2005 Jul 28. Cell Cycle. 2005. PMID: 15917650

2

Macrophage colony-stimulating factor receptor c-fms is a novel target of imatinib.

Dewar AL, Cambareri AC, Zannettino AC, Miller BL, Doherty KV, Hughes TP, Lyons AB. Dewar AL, et al. Among authors: lyons ab. Blood. 2005 Apr 15;105(8):3127-32. doi: 10.1182/blood-2004-10-3967. Epub 2005 Jan 6. Blood. 2005. PMID: 15637141 Free article.

3

Imatinib inhibits the functional capacity of cultured human monocytes.

Dewar AL, Doherty KV, Hughes TP, Lyons AB. Dewar AL, et al. Among authors: lyons ab. Immunol Cell Biol. 2005 Feb;83(1):48-56. doi: 10.1111/j.1440-1711.2004.01296.x. Immunol Cell Biol. 2005. PMID: 15661041

4

In vitro sensitivity to imatinib-induced inhibition of ABL kinase activity is predictive of molecular response in patients with de novo CML.

White D, Saunders V, Lyons AB, Branford S, Grigg A, To LB, Hughes T. White D, et al. Among authors: lyons ab. Blood. 2005 Oct 1;106(7):2520-6. doi: 10.1182/blood-2005-03-1103. Epub 2005 Jun 14. Blood. 2005. PMID: 15956284 Free article.

5

Drug-interaction studies evaluating T-cell proliferation reveal distinct activity of dasatinib and imatinib in combination with cyclosporine A.

Blake SJ, Hughes TP, Lyons AB. Blake SJ, et al. Among authors: lyons ab. Exp Hematol. 2012 Aug;40(8):612-21.e6. doi: 10.1016/j.exphem.2012.04.003. Epub 2012 Apr 19. Exp Hematol. 2012. PMID: 22521768 Free article.

6

Imatinib inhibits the in vitro development of the monocyte/macrophage lineage from normal human bone marrow progenitors.

Dewar AL, Domaschenz RM, Doherty KV, Hughes TP, Lyons AB. Dewar AL, et al. Among authors: lyons ab. Leukemia. 2003 Sep;17(9):1713-21. doi: 10.1038/sj.leu.2403071. Leukemia. 2003. PMID: 12970769

7

The Src/ABL kinase inhibitor dasatinib (BMS-354825) inhibits function of normal human T-lymphocytes in vitro.

Blake S, Hughes TP, Mayrhofer G, Lyons AB. Blake S, et al. Among authors: lyons ab. Clin Immunol. 2008 Jun;127(3):330-9. doi: 10.1016/j.clim.2008.02.006. Epub 2008 Apr 18. Clin Immunol. 2008. PMID: 18395492

8

Dasatinib inhibits recombinant viral antigen-specific murine CD4+ and CD8+ T-cell responses and NK-cell cytolytic activity in vitro and in vivo.

Fraser CK, Blake SJ, Diener KR, Lyons AB, Brown MP, Hughes TP, Hayball JD. Fraser CK, et al. Among authors: lyons ab. Exp Hematol. 2009 Feb;37(2):256-65. doi: 10.1016/j.exphem.2008.09.013. Epub 2008 Dec 3. Exp Hematol. 2009. PMID: 19056158 Free article.

9

Nilotinib inhibits the Src-family kinase LCK and T-cell function in vitro.

Blake SJ, Lyons AB, Hughes TP. Blake SJ, et al. Among authors: lyons ab. J Cell Mol Med. 2009 Mar;13(3):599-601. doi: 10.1111/j.1582-4934.2009.00500_1.x. J Cell Mol Med. 2009. PMID: 19374687 Free PMC article. No abstract available.

10

Acquisition of immune function during the development of the Langerhans cell network in neonatal mice.

Dewar AL, Doherty KV, Woods GM, Lyons AB, Muller HK. Dewar AL, et al. Among authors: lyons ab. Immunology. 2001 May;103(1):61-9. doi: 10.1046/j.1365-2567.2001.01221.x. Immunology. 2001. PMID: 11380693 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

145 results

Search Page

Filters